prostate cancer

Also found in: Thesaurus, Medical, Financial, Acronyms, Encyclopedia, Wikipedia.
ThesaurusAntonymsRelated WordsSynonymsLegend:
Noun1.prostate cancer - cancer of the prostate gland
adenocarcinoma, glandular cancer, glandular carcinoma - malignant tumor originating in glandular epithelium
References in periodicals archive ?
If this study shows a reduction in cancer rates anywhere near what we've seen in earlier trails, it would put a dent in the 200,000 new cases of prostate cancer we see annually," says NCI researcher Demetrius Albanes.
This peer review recognition at the ASCO Prostate Cancer Symposium, along with the recent attention in the scientific literature and lay press, underscores the importance of having a treatment for these multiple serious side effects of ADT," said Mitchell S.
In 1994, researchers began recruiting healthy men over age 55 who showed no signs of prostate cancer in physical examinations and blood tests.
Guests will get a packet of information about prostate cancer, its detection and options for treatment.
Onyvax-P is a therapeutic prostate cancer vaccine designed to elicit a powerful and specific immune response against prostate cancer cells without the severe side effects often associated with conventional cancer therapies.
1) By 1992, 812 of the men had been diagnosed with prostate cancer, almost always in its earliest, localized stage.
Phase I/II Trial of CB7630 (Abiraterone Acetate) in Patients with Hormone Refractory, Chemotherapy Naove, Prostate Cancer
There is a wealth of evidence that farmers tend to be at high risk of prostate cancer," says Marie-Elise Parent, a cancer epidemiologist at the University of Quebec in Laval, who isn't involved in the new study.
Bethune continued, "This type of treatment has become a mainstay therapy for advanced prostate cancer as evidenced by $1.
Although more lives are being saved through early detection, African- American men continue to show disproportionately higher numbers of deaths from prostate cancer.
Eventually, one in 11 men will get prostate cancer.
Cytogen Corporation (NASDAQ: CYTO) today reported the publication of a seven-year survival study that suggests PROSTASCINT([R]) may help predict which patients are less likely to benefit from brachytherapy for prostate cancer.